Published online Nov 5, 2021. doi: 10.5495/wjcid.v11.i3.38
Peer-review started: June 27, 2021
First decision: July 31, 2021
Revised: August 14, 2021
Accepted: October 15, 2021
Article in press: October 15, 2021
Published online: November 5, 2021
Processing time: 127 Days and 10.6 Hours
Sexually transmitted infections are among the most prevalent diseases worldwide, which is considered a public health issue. In immunocompetent individuals, human papillomavirus (HPV) is usually eliminated within 18 mo after infection. However, several studies have been pointing out the relationship between the infection by HIV and HPV, indicating a higher risk of papillomavirus infection in individuals with immune suppression. HPV has also a close relationship with the emergence of cancer in the perianal region, especially in individuals with weakened immune system, such as those who are seropositive for HIV.
In the above-mentioned context, it is essential to compile results of studies evaluating the coinfection with these viruses and demonstrating associated risk factors that contribute to the occurrence of anal changes by HPV. Since HPV is an agent legitimately associated with the occurrence of cancer, in public health management, it is extremely important to recommend a close follow-up of these people, which can change the natural history of HPV disease.
This study aimed to explore the prevalence of anal HPV infection in HIV-seropositive patients as well as to list risk factors associated with this event.
For this systematic review, PRISMA recommendation was followed. Articles on the prevalence and risk factors associated with HPV infection in anal and perianal sites in HIV-seropositive patients from January 2010 to April 2020 that were published in English, Portuguese, and Spanish were selected and analyzed.
Ten articles were selected, and all of them addressed risk factors linked to a higher prevalence of HPV infection in individuals infected with HIV. This study reinforced the understanding that the most important factor for the presence of anal HPV infection is HIV seropositivity.
The analysis of the articles points to a higher prevalence of anal HPV infection in patients infected with HIV, those with multiple partners, alcohol and drug users, and those with early age of first sexual intercourse with same-sex individuals. Number of partners, absence of condom use, anal intercourse, multiple partners, sexual and life habits and HIV are among the risk factors associated with anal HPV infection.
We initially expected a greater number of articles, which may indicate the need for further studies on this theme. This review points out associated factors which in many cases can be modified, which has the potential to greatly contribute to reducing the incidence of high-grade lesions and anal cancer.